| ASSET | YEAR | % RETURN |
|---|---|---|
ANI Pharmaceuticals (ANIP) | 2015 | -20.27% |
ANI Pharmaceuticals (ANIP) | 2016 | 36.16% |
ANI Pharmaceuticals (ANIP) | 2017 | 6.13% |
ANI Pharmaceuticals (ANIP) | 2018 | -30.91% |
ANI Pharmaceuticals (ANIP) | 2019 | 38.83% |
ANI Pharmaceuticals (ANIP) | 2020 | -53.31% |
ANI Pharmaceuticals (ANIP) | 2021 | 60.84% |
ANI Pharmaceuticals (ANIP) | 2022 | -13.71% |
ANI Pharmaceuticals (ANIP) | 2023 | 34.98% |
ANI Pharmaceuticals (ANIP) | 2024 | 0.86% |
ANI Pharmaceuticals (ANIP) | 2025 | 68.17% |
